ProCE Banner Activity

The Evolving Therapeutic Landscape for HER2-Positive Early-Stage Breast Cancer

Slideset Download
Download this slideset from Lee Schwartzberg, MD, FACP to review key data on optimal treatment for HER2-positive early breast cancer, including neoadjuvant and adjuvant therapy.

Released: August 10, 2020

Expiration: August 09, 2021

Share

Faculty

Lee Schwartzberg

Lee Schwartzberg, MD

Professor of Medicine
Chief
Division of Hematology and Oncology
University of Tennessee Health Science Center
Memphis, Tennessee
Executive Director
West Cancer Center
Germantown, Tennessee

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Puma Biotechnology, Inc.

Faculty Disclosure

Primary Author

Lee Schwartzberg, MD

Professor of Medicine
Chief
Division of Hematology and Oncology
University of Tennessee Health Science Center
Memphis, Tennessee
Executive Director
West Cancer Center
Germantown, Tennessee